Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.

Of all lawsuits filed against patients in 2024 in one U.S. state, physician practices and other non-hospital healthcare entities accounted for 80% of cases. That’s a complete inversion from just six years prior.  

In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages? 

The U.S. Department of Justice said it worries its lawsuit could ultimately bankrupt the telehealth group, leaving little money for alleged victims. The company is said to have refused to cancel member accounts, forcing patients to file credit card disputes to get refunds. This is in addition to other arguably more serious accusations levied by the DOJ.

The idea was floated as part of a proposed budget for the state released by Democrats in the Senate. If passed, only the top 2% of corporations in California would be impacted. The levy would generate $5 billion to $8 billion annually for Medicaid. 

Cardiologists in the United States now earn an average annual income of $575,000. That represents an increase of 10% compared to the previous year.

Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”

HB 1364, a bill some radiologists pushed back against, is headed to the Governor’s desk to be finalized. It is set to take effect on Oct. 1.